Multisystemic inflammatory syndrome post-COVID-19: A new emerging entity

Authors

  • Vijay B Sonawane
  • Veeranna Kotrashetti
  • Kapil Bainade
  • V Trisha
  • Saili Bunde
  • Saniya Sroa

DOI:

https://doi.org/10.32677/IJCR.2021.v07.i06.011

Keywords:

Multisystem inflammatory syndrome, Pediatric inflammatory multisystem syndrome, Post-COVID

Abstract

Multisystem inflammatory syndrome in children (MISC-C), also known as the pediatric inflammatory multisystem syndrome, is a new dangerous childhood disease that may be associated with COVID disease. Signs and symptoms depend on the body part involved. We report a case of complicated post-COVID MIS-C in a 5-year-old child who presented with fever, vomiting, pain abdomen for 6 days, and rash for 2 days. Since the patient had complaints of high-grade fever for more than 5 days, rash, non-purulent conjunctivitis, cracked lips with cardiac and respiratory, and gastrointestinal involvement with positive COVID antibodies, and raised CRP; she was diagnosed to have the MIS-C post-COVID. The patient was started on oral aspirin and oral prednisolone for 2 weeks and discharged with proper advice.

Downloads

Download data is not yet available.

Downloads

Published

2021-06-28

Issue

Section

Case Report

How to Cite

Multisystemic inflammatory syndrome post-COVID-19: A new emerging entity. (2021). Indian Journal of Case Reports, 7(6), 254-256. https://doi.org/10.32677/IJCR.2021.v07.i06.011

Most read articles by the same author(s)

<< < 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133